Establishment Labs Holdings Inc. (ESTA) · Oct 29, 2026 · Earnings

Establishment Labs earnings beat revenue bar, EPS still misses

Mixed results — Revenue $72.0M vs ~$66.8M consensus; GAAP EPS $(0.35) vs ~$(0.26)

Establishment Labs’ Q3 earnings show accelerating revenue, operating leverage and first-ever positive quarterly free cash flow, offset by a GAAP EPS miss.

Establishment Labs is scaling a breast-aesthetics and reconstruction device platform, with U.S. sales and minimally invasive products becoming the main growth vectors. Its prior quarter had already raised fiscal 2026 revenue guidance and pointed to a second-half cash-flow inflection, so this release confirms a trajectory that was partly established rather than introducing an entirely new story.

Revenue materially cleared the market’s bar. Q3 revenue reached $72.0 million, 33.9% above last year and roughly 7.8% above the published consensus of about $66.8 million. U.S. revenue grew 119%, while minimally invasive revenue more than doubled to approximately $9 million, showing that the intended commercial expansion is translating into reported sales.

The operating model is improving faster than the GAAP bottom line. Adjusted EBITDA rose to $6.4 million from $1.2 million a year ago, and adjusted operating expenses fell to 68.8% of revenue from 77.6%. Adjusted gross margin also improved to 70.8%, although GAAP gross margin declined to 69.1% because of $1.3 million of restructuring-related inventory charges.

Cash generation is the quarter’s most meaningful business milestone. The company produced $7.7 million of operating cash flow and $5.1 million of free cash flow, its first positive quarterly free-cash-flow result. That is a clear advance from the prior-year cash burn, but nine-month free cash flow remains negative at $21.4 million, so the turnaround is not yet proven over a full year.

The earnings miss keeps the result from being a clean beat. GAAP loss per share was $(0.35), wider than the roughly $(0.26) consensus loss, despite the revenue outperformance and better operating leverage. Interest expense of $6.8 million remains a meaningful drag, while net debt is substantial relative to the $75.8 million cash balance; the balance sheet therefore still depends on continued growth and cash-flow execution. The release also introduced a fiscal 2027 target of 25% growth and positive cash flow, but that is management’s outlook rather than a benchmark with an established consensus. 〔0〕

MetricQ3 2026Q3 2025Consensus / comparison
Revenue (Financial Statements)$72.0M (+33.9%)$53.8M~$66.8M
GAAP EPS (Financial Statements)$(0.35)$(0.38)~$(0.26)
Adjusted EBITDA (Adjusted EBITDA reconciliation)$6.4M$1.2M
Adjusted gross margin (Adjusted gross profit reconciliation)70.8%70.1%
Free cash flow (Free cash flow reconciliation)$5.1M$(13.2M)
Cash and equivalents (Balance Sheet)$75.8M$75.6M at Dec. 31
FY2027 growth guide (Press release)25%

Bottom line: This was a genuine operating improvement, led by revenue, cost leverage and the first positive quarterly cash flow. But the GAAP EPS miss and still-levered balance sheet make it a mixed earnings read rather than a clean upside surprise.

What to watch next

Q4 report and FY2027 outlook update

Original filing on SEC EDGAR

More Establishment Labs Holdings Inc. news

Establishment Labs earnings beat revenue bar, EPS still misses | ESTA Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.